Financhill
Back

EyePoint Pharmaceuticals Vs. Regenxbio Industry Stock Comparison

Buy
56

EYPT
EyePoint Pharmaceuticals

Last Price:
12.05
Seasonality Move:
19.48%
Sell
30

RGNX
Regenxbio

Last Price:
9.38
Seasonality Move:
0.61%
Buy
56
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $11.61. The Score for EYPT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Regenxbio (RGNX) is a Sell

Is Regenxbio a Buy, Sell or Hold?

  • The current Regenxbio [RGNX] share price is $8.92. The Score for RGNX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $11.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGNX Stock Price Chart

What is Regenxbio's stock price today?

  • The Regenxbio share price today is $8.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 61.26 Buy
Chaikin Money Flow: 288172 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.64 - 11.44) Buy
Bollinger Bands (100): (8.05 - 10.13) Buy

RGNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.54 Sell
Relative Strength Index (14 RSI): 37.75 Sell
Chaikin Money Flow: 270845 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.98 - 10.22) Sell
Bollinger Bands (100): (10.11 - 12.95) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.47 Buy
20-day SMA: 10.45 Buy
50-day SMA: 9.29 Buy
200-day SMA: 14.61 Sell
8-day EMA: 11.42 Buy
20-day EMA: 10.64 Buy
50-day EMA: 9.83 Buy
200-day EMA: 11.64 Sell

RGNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.96 Sell
20-day SMA: 9.56 Sell
50-day SMA: 10.68 Sell
200-day SMA: 14.43 Sell
8-day EMA: 9.02 Sell
20-day EMA: 9.52 Sell
50-day EMA: 10.47 Sell
200-day EMA: 13.59 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.83 per share.

Regenxbio Earnings Growth & RGNX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.00 per share, and an increase next year of $3.77 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regenxbio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):